QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, September 3, 2003, 23(22):8029-8033

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (20) Citing Articles via Google Scholar Google Scholar Articles by Bresjanac, M. Articles by Popovic, M. Search for Related Content PubMed PubMed Citation Articles by Bresjanac, M. Articles by Popovic, M.

 Previous Article  |  Next Article 

BRIEF COMMUNICATION
Molecular-Imaging Probe 2-(1-{6-[(2-Fluoroethyl)(Methyl) Amino]-2-Naphthyl}Ethylidene) Malononitrile Labels Prion Plaques In Vitro

Mara Bresjanac,^1,2 Lojze M. Smid,^1,2 Tomaz D. Vovko,^1,2 Andrej Petri,³ Jorge R. Barrio,⁴ and Mara Popovic²

¹Laboratory for Neuronal Plasticity and Regeneration, Institute of Pathophysiology, ²Prion Laboratory, Institute of Pathology, School of Medicine, and ³Faculty of Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia, and ⁴Division of Nuclear Medicine, Department of Molecular and Medical Pharmacology, Laboratory of Structural Biology and Molecular Medicine, University of California, Los Angeles, School of Medicine, Los Angeles, California 90095

The study aimed to evaluate the fluorescent molecular-imaging probe 2-(1-{6-[(2-fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile (FDDNP) for its ability to selectively and reproducibly label prion plaques in fixed, paraffin-embedded cerebellar sections from patients of confirmed Gerstmann-Sträussler-Scheinker disease, sporadic Creutzfeldt-Jacob disease (CJD) with kuru plaques, and variant CJD (vCJD). FDDNP is a highly hydrophobic, viscosity-sensitive, solvent-sensitive, fluorescent substance, whose radiofluorinated analog [¹⁸F]FDDNP has recently been successfully used to label senile plaques and neurofibrillary tangles in the living brain of Alzheimer's disease patients with positron emission tomography. Our results show that FDDNP reliably identifies all prion plaques, including small cluster-plaques in vCJD. This finding may open new in vivo diagnostic possibilities for vCJD.

Key words: fluorescent labeling; human; neuroimaging; TSE; variant Creutzfeldt-Jacob disease; amyloid

---

Received April 8, 2003; revised May 27, 2003; accepted July 14, 2003.

This article has been cited by other articles:

				Y. Kawasaki, K. Kawagoe, C.-j. Chen, K. Teruya, Y. Sakasegawa, and K. Doh-ura Orally Administered Amyloidophilic Compound Is Effective in Prolonging the Incubation Periods of Animals Cerebrally Infected with Prion Diseases in a Prion Strain-Dependent Manner J. Virol., December 1, 2007; 81(23): 12889 - 12898. [Abstract] [Full Text] [PDF]

				A. L. Boxer, G. D. Rabinovici, V. Kepe, J. Goldman, A. J. Furst, S. -C. Huang, S. L. Baker, J. P. O'Neil, H. Chui, M. D. Geschwind, et al. Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease Neurology, July 17, 2007; 69(3): 283 - 290. [Abstract] [Full Text] [PDF]

				R G Macfarlane, S J Wroe, J Collinge, T A Yousry, and H R Jager Neuroimaging findings in human prion disease J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 664 - 670. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help